Tags : Intravacc

PharmaShots Weekly Snapshot (Jun 01-05, 2020)

1. Novartis Reports Results of Enerzair Breezhaler (QVM149) in P-IIIb ARGON Study to Treat Uncontrolled Asthma Published: Jun 04, 2020 | Tags: Novartis, Reports, Enerzair Breezhaler, QVM149, P-IIIb, ARGON Study, Treat, Uncontrolled Asthma 2. Melinta Therapeutics to Acquire Tetraphase Pharmaceuticals Published: Jun 04, 2020 | Tags: Melinta Therapeutics, Acquire, Tetraphase Pharmaceuticals 3. AstraZeneca Signs an Agreement with […]Read More

Intravacc and EpiVax Collaborate to Develop an Emerging Vaccine for

Shots: Intravacc signs an agreement with EpiVax for the development of novel vaccine against COVID-19, based on Intravacc’s Outer Membrane Vesicles (OMV) technology platform The collaboration will combine Intravacc’s OMV delivery platform with synthetically produced COVID-19 epitopes from EpiVax’ immunoinformatics toolbox. The focus of the collaboration is to generate safe and effective adaptive immunity against […]Read More